Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin Choy

Showing results (111-120 of 180) with videos related to

Pageof 18
Sort By:
Cancer Immunology Research|May 29, 2014
Programmed cell death ligand 1 expression in osteosarcomaJacson K Shen, Gregory M Cote, Edwin Choy, et al.
European Journal of Cancer (Oxford, England : 1990)|October 25, 2012
Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective studyNicole J Look Hong, Francis J Hornicek, David C Harmon, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 4, 2020
Percutaneous Cryoablation: Safety and Efficacy for Pain Palliation of Metastases to Pleura and Chest WallFlorian J Fintelmann, Platon Braun, Syed Hamad Mirzan, et al.
Cancer|March 31, 2011
Proton-based radiotherapy for unresectable or incompletely resected osteosarcomaI Frank Ciernik, Andrzej Niemierko, David C Harmon, et al.
International Journal of Radiation Oncology, Biology, Physics|August 6, 2018
A Phase 1 Study of Nilotinib Plus Radiation in High-Risk ChordomaGregory M Cote, Constance M Barysauskas, Thomas F DeLaney, et al.
Head and Neck Pathology|March 25, 2024
A Comparison of Clear Cell Sarcoma to Jaw and Salivary Tumors Bearing EWS FusionsOrnela Xhori, Navkiran Deol, Camron M Rivera, et al.
The Lancet. Oncology|July 23, 2013
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 studySant Chawla, Robert Henshaw, Leanne Seeger, et al.
The Lancet. Oncology|November 10, 2019
Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 studySant Chawla, Jean-Yves Blay, Piotr Rutkowski, et al.
The Oncologist|May 28, 2017
Localized Adult Ewing Sarcoma: Favorable Outcomes with Alternating Vincristine, Doxorubicin, Cyclophosphamide, and Ifosfamide, Etoposide (VDC/IE)-Based Multimodality TherapyJennifer L Pretz, Constance M Barysauskas, Suzanne George, et al.
Anticancer Research|June 17, 2009
Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordomaJoseph Schwab, Cristina Antonescu, Patrick Boland, et al.
Pageof 18

Showing results (111-120 of 180) with videos related to

Sort By:
Pageof 18
Cancer Immunology Research|May 29, 2014
Programmed cell death ligand 1 expression in osteosarcomaJacson K Shen, Gregory M Cote, Edwin Choy, et al.
European Journal of Cancer (Oxford, England : 1990)|October 25, 2012
Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective studyNicole J Look Hong, Francis J Hornicek, David C Harmon, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 4, 2020
Percutaneous Cryoablation: Safety and Efficacy for Pain Palliation of Metastases to Pleura and Chest WallFlorian J Fintelmann, Platon Braun, Syed Hamad Mirzan, et al.
Cancer|March 31, 2011
Proton-based radiotherapy for unresectable or incompletely resected osteosarcomaI Frank Ciernik, Andrzej Niemierko, David C Harmon, et al.
International Journal of Radiation Oncology, Biology, Physics|August 6, 2018
A Phase 1 Study of Nilotinib Plus Radiation in High-Risk ChordomaGregory M Cote, Constance M Barysauskas, Thomas F DeLaney, et al.
Head and Neck Pathology|March 25, 2024
A Comparison of Clear Cell Sarcoma to Jaw and Salivary Tumors Bearing EWS FusionsOrnela Xhori, Navkiran Deol, Camron M Rivera, et al.
The Lancet. Oncology|July 23, 2013
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 studySant Chawla, Robert Henshaw, Leanne Seeger, et al.
The Lancet. Oncology|November 10, 2019
Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 studySant Chawla, Jean-Yves Blay, Piotr Rutkowski, et al.
The Oncologist|May 28, 2017
Localized Adult Ewing Sarcoma: Favorable Outcomes with Alternating Vincristine, Doxorubicin, Cyclophosphamide, and Ifosfamide, Etoposide (VDC/IE)-Based Multimodality TherapyJennifer L Pretz, Constance M Barysauskas, Suzanne George, et al.
Anticancer Research|June 17, 2009
Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordomaJoseph Schwab, Cristina Antonescu, Patrick Boland, et al.
Pageof 18